iShares Nasdaq Biotechnology (IBB) puts after Biogen (BIIB) discontinues two Alzheimer's trials

iShares Nasdaq Biotechnology (NASDAQ: IBB) March weekly call option implied volatility is at 24, April is at 20; compared to its 52-week range of 15 to 40 after Biogen (BIIB) discontinues two Alzheimer's trials. Call put ratio 1 call to 3.3 puts with focus on June 100 puts.

You May Also Be Interested In

• Copart (CPRT) call put ratio 1.8 calls 1 put a share price up 3.9%
• SpaceX (SPCX) spreader of 3500 contracts of November 90 and 100 puts as share price up 5%
• Palantir (PLTR) September 4 weekly 187.50 and 192.50 calls as share price up 7%